We combine our cardiac biology knowhow with our expertise in bio-engineering and human induced pluripotent stem cells (hiPSC) to develop 3D cardiac in vitro models for the discovery and development of novel cardiac drugs.
Location: Netherlands, Overijssel, Enschede
Member count: 1-10
Total raised: $2.243183M
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 19.07.2023 | Seed | $2.243183M | - | siliconcan... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 19.07.2023 | Dutch biot... | Read this article in: Ensched... | funding n... | Vishal Sin... | siliconcan... |
| 05.07.2023 | River BioM... | River BioMedics portfolio is f... | - | - | oostnl.com... |
| 30.12.2022 | Dutch-base... | The Netherlands is swiftly ris... | biotech f... | Vishal Sin... | siliconcan... |